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1. Introduction
The incidence of diabetes has been predicted to increase to 21% by 2050. In 
various continents, the rise in the global diabetes epidemic has been associated 
with diseases of various organs related to obesity, diabetes and neurodegenerative 
diseases [1]. Type 2 diabetes is now connected to Type 3 diabetes that involves the 
brain early in life associated with various brain diseases such as stroke, dementia, 
and Alzheimer’s disease. Sugar intake is now critical to healthy aging and deter-
mines mitochondrial survival [2] and the lifespan of diabetics in the developing 
and developed world (Figure 1). The risk of sugar (glucose, fructose) intake is 
associated with amyloid-beta aggregation and programmed cell death relevant to 
neurodegeneration and Alzheimer’s disease. Insulin therapy and sugar intake are 
closely connected to the global non-alcoholic fatty liver disease (NAFLD) with insu-
lin therapy inactivation associated with the induction of NAFLD [1]. Food quality 
[3] is critical to the global diabetes epidemic with recalculation of daily sugar intake 
essential to maintain the anti-aging gene and to reverse accelerated aging, NAFLD 
and neurodegeneration.
The guidelines on dietary sugar require critical recommendations [4] with 
relevance to functional food science. Food scientists indicate that functional foods 
contain biologically active compounds that have advantageous physiological effects 
that play an important role in the prevention of insulin resistance. Nutritional science 
provides functional foods with the required amounts of natural compounds [5] that 
prevent mitophagy and reverse programmed cell death. This book contains chapters 
that assist food scientists with relevance to sugar intake (risks and  benefits) and are 
Figure 1. 
The role of sugar intake is critical to mitochondrial survival that is connected to diabetes, NAFLD and 
Alzheimer’s disease.
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important to the critical role played by functional foods in the treatment of individu-
als from the global chronic disease. The chapters published in this book are from 
various authors around the world. These authors have written excellent chapters that 
maintain the high standards for the best book companies. The quality of the research 
contributed in chapters include research on the impact of sugar on vision, use of 
pedometer for the management of impaired glucose intolerance, fructose intake with 
relevance to metabolism and severity in chronic diseases. The role of organs involved 
in glucose metabolism and the effect of ad framing on the intention to control sugar 
intake is assessed. The biological responses to the consumption of non-nutritional 
sweeteners is assessed with the role of hyperglycemia and hyperlipidemia induced 
activation of human T lymphocytes and inflammation and inhibition by ω- 3 Fatty 
Acid. The research on critical elements of dietary carbohydrates and the metabolic 
syndrome with relevance to the sugars with the potential to prolong human life 
are discussed in this scholarly book. The research contributed in these chapters 
by the authors is of key  interest to functional foods and the current global chronic 
disease epidemic. The role of anti-aging genes [6, 7] are of critical interest that 
when activated will reverse impaired glucose tolerance, improve vision, extend life 
and improve the metabolic syndrome in diabetes. The research mentioned in these 
chapters will improve the anti-aging gene release of anti-aging proteins [8] that are 
critical to longevity and reversal of the global chronic disease epidemic. The risk and 
benefits of sugar intake as outlined in this book may revolve around the activation 
and repression of the anti-aging gene that is critical to mitochondrial survival and if 
the question with relevance to risks and benefits of sugar intake remains unanswered 
it may lead to the predicted global increase in NAFLD, diabetes and neurodegenerative 
disease by the year 2050.
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